[1]Aoki J, Ikari Y. Cardiovascular Disease in Patients with End-Stage Renal Disease on Hemodialysis[J]. Ann Vasc Dis, 2017, 10(4): 327-337.
[2]Karkhanis Reena,Tam Derrick Y,Fremes Stephen E. Management of patients with end-stage renal disease: coronary artery bypass graft surgery versus percutaneous coronary intervention[J].Current Opinion In Cardiology, 2018, 33(5): 546-550.
[3]Charles A Herzog, William L Henrich, Alfred K Cheung. Overview of the management and prevention of heart failure in dialysis patients,UpToDate, 2020: 1-9.
[4]McCullough Peter A,Chan Christopher T,Weinhandl Eric D,et al. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease[J]. American journal of kidney diseases : the official journal of the National Kidney Foundation,2016,68(5): S5-S14.
[5]Zoccali C,Tripepi G, Mallamaci F,et al. Cardiac Consequences of Hypertension in Hemodialysis Patients[J]. Seminars in Dialysis, 2004,17(4): 299-303.
[6]Burlacu A,Genovesi S,Basile C,et al. Coronary artery disease in?dialysis patients: evidence synthesis, controversies and?proposed management strategies[J]. Journal of Nephrology, 2020.
[7]Yao-Min Hung,Yu-Yen Chen,Wei-Chun Huang,et al. Association Between Dialysis Modalities and Risk of Coronary Artery Disease: A Population-Based Cohort Study in Taiwan[J]. Ther Apher Dial 2018, 22(5): 469-475.
[8]Charles A Herzog, William L Henrich. Secondary prevention of cardiovascular disease in end-stage renal disease (dialysis), 2020:1-16.
[9]Sarnak MJ, Amann K, Bangalore S, et al. Chronic Kidney Disease and Coronary Artery Disease[J]. J Am Coll Cardiol, 2019,74(14): 1823-1838.
[10]Inaguma D, Takahashi K, Hayashi H, et al. Relationship between history of coronary heart disease at dialysis initiation and onset of events associated with heart disease: a propensity-matched analysis of a prospective cohort study[J]. BMC Nephrology, 2017,18(1):79.
[11]Tyrone G. Harrison,Caley B. Shukalek,Brenda R. Hemmelgarn,et al. Association of NT-proBNP and BNP With Future Clinical Outcomes in Patients With ESKD: A Systematic Review and Meta-analysis[J]. American Journal of Kidney Diseases, 2020,76(2): 233-247.
[12]Herzog CA, Littrell K, Arko C, et al. Clinical characteristics of dialysis patients with acute
myocardial infarction in the United States: a collaborative project of the United States Renal
Data System and the National Registry of Myocardial Infarction. Circulation 2007;116:1465.
[13]Jin Jingjing,Guo Xiaoyang,Yu Qiyao.Effects of Beta-Blockers on Cardiovascular Events and Mortality in Dialysis Patients: A Systematic Review and Meta-Analysis[J]. Blood Purif, 2019,48(1): 51-59.
[14] Luca Di Lullo ,A.H., Antonio Gorini ,et al. Chronic kidney disease and cardiovascular complications[J]. Heart Fail Rev, 2014.
[15] Agrawal H, Aggarwal K, Littrell R, et al. Pharmacological and non pharmacological strategies in the management of coronary artery disease and chronic kidney disease[J]. Curr Cardiol Rev. 2015,11(3):261-9.?
[16]Marrs Joel C,Saseen Joseph J. Effects of Lipid-Lowering Therapy on Reduction of Cardiovascular Events in Patients with End-Stage Renal Disease Requiring Hemodialysis[J]. Pharmacotherapy, 2010,30(8): 823-829.
[17]D. Benson Walker,Thanh Jennifer Walker,Terry A. Jacobson,et al.Chronic Kidney Disease and Statins: Improving Cardiovascular Outcomes[J]. Cardiovascular Disease and Stroke, 2009, 11(4): 301-308.
[18]Palmer Suetonia C,Navaneethan Sankar D,Craig Jonathan C,et al. HMG-CoA reductase inhibitors(statins) for dialysis patients[J]. Cochrane Database Syst Rev, 2013,(9): CD004289.
[19]Tam Derrick Y,Rahouma Mohamed,An Kevin R,et al. Bilateral versus single internal thoracic artery for coronary artery bypass grafting with end-stage renal disease: A systematic review and meta‐analysis[J]. Journal of cardiac surgery,2019,34(4):1-6.
[20]John A. Spertus,Philip G. Jones,David J. Maron,et al.Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease[J]. The new england journal of medicine, 2020, 382(17): 1619-1628.
[21]Kannan A,Poongkunran C,Medina R, et al. Coronary Revascularization in Chronic and End-Stage Renal Disease: A Systematic Review and Meta-analysis[J]. American Journal of Therapeutics,2016,23(1):e16-e28.
[22]Wu P,Luo F ,Fang Z. Multivessel Coronary Revascularization Strategies in Patients with Chronic Kidney Disease: A Meta-Analysis[J]. Cardiorenal Med, 2019,9(3): 145-159.
